A Microneedle Device for Rapid Dermal Interstitial Fluid Sampling
Hung, A. H.; Rajesh, N. U.; Bermudez, A.; Boczek, S. M.; Garcia-Marques, F. J.; Tan, Y. L.; Hwang, J.; Sinawang, P. D.; Ilyin, D.; Jacobson, G. B.; Demirci, U.; Poplack, S. P.; Pitteri, S. J.; DeSimone, J. M.
Show abstract
Dermal interstitial fluid (ISF) offers a promising alternative to invasive blood tests and opportunities for novel skin diagnostics. Progress in both the understanding and adoption of ISF tests is hindered by sampling challenges, including lengthy collection times, non-negligible failure rates, variable collection volumes, and inconsistent bioanalyte levels. The causes of many of these issues are not well understood. We demonstrate a microneedle device that is several times faster than state-of-the-art, collecting an average of 15.5 mg of ISF in 5 minutes in humans with near-zero failure rate. This improvement was achieved by designing the spatial pressure gradient driving ISF flow. The influence of penetration depth, collection time, pressure, and age on ISF collection was elucidated, with Darcys law explaining multiple observations. A data-driven acceptance criterion of <1% blood contamination for ISF is proposed. The device and findings presented will empower researchers to better conduct robust studies in the development of ISF diagnostics.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Injection molded open microfluidic well plate inserts for user-friendly coculture and microscopy 93%
- Establishment of physiologically relevant oxygen gradients in microfluidic organ chips 93%
- A 3D-printed multi-compartment organ-on-chip platform with a tubing-free pump models communication with the lymph node 93%
Similar papers in this journal
Similar papers in this journal
- Dissolved gases from pressure changes in the lungs elicit an immune response in human peripheral blood 91%
- Stable nebulization and muco-trapping properties of Regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19 90%
- Predicting T Cell Quality During Manufacturing Through an Artificial Intelligence-based Integrative Multi-Omics Analytical Platform 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.